Similarly, administration of IFNγ reduced fibrosis in rat models of hepatic fibrosis [143], and long-term administration of IFNγ reduced fibrosis in patients with chronic Hepatitis B infections [144]. The gene discussed is IFNG; the disease is Hepatic fibrosis.